- Home
- ALUR vs DXR Comparison
ALUR vs DXR Comparison
Compare ALUR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALUR
- DXR
- Stock Information
- Founded
- ALUR 2009
- DXR 1970
- Country
- ALUR United States
- DXR United States
- Employees
- ALUR N/A
- DXR N/A
- Industry
- ALUR
- DXR Medical/Dental Instruments
- Sector
- ALUR
- DXR Health Care
- Exchange
- ALUR Nasdaq
- DXR Nasdaq
- Market Cap
- ALUR 22.5M
- DXR 37.6M
- IPO Year
- ALUR N/A
- DXR N/A
- Fundamental
- Price
- ALUR $3.14
- DXR $8.43
- Analyst Decision
- ALUR Strong Buy
- DXR Strong Buy
- Analyst Count
- ALUR 4
- DXR 1
- Target Price
- ALUR $75.00
- DXR $24.75
- AVG Volume (30 Days)
- ALUR 67.5K
- DXR 7.5K
- Earning Date
- ALUR 11-13-2024
- DXR 01-01-0001
- Dividend Yield
- ALUR N/A
- DXR N/A
- EPS Growth
- ALUR N/A
- DXR N/A
- EPS
- ALUR N/A
- DXR 0.35
- Revenue
- ALUR $34,754,000.00
- DXR $154,205.00
- Revenue This Year
- ALUR N/A
- DXR N/A
- Revenue Next Year
- ALUR $2.22
- DXR N/A
- P/E Ratio
- ALUR N/A
- DXR $23.67
- Revenue Growth
- ALUR N/A
- DXR N/A
- 52 Week Low
- ALUR $2.72
- DXR $7.19
- 52 Week High
- ALUR $98.75
- DXR $10.03
- Technical
- Relative Strength Index (RSI)
- ALUR 26.80
- DXR 53.81
- Support Level
- ALUR $2.72
- DXR $7.70
- Resistance Level
- ALUR $9.10
- DXR $8.51
- Average True Range (ATR)
- ALUR 2.10
- DXR 0.35
- MACD
- ALUR -0.60
- DXR 0.09
- Stochastic Oscillator
- ALUR 3.81
- DXR 92.59
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.